Wiesenbach, Germany

Aurelien Olichon



 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Noé, FR (2013)
  • Wiesenbach, DE (2016)

Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Aurelien Olichon: Innovator in Rotavirus Treatment

Introduction

Aurelien Olichon is a notable inventor based in Wiesenbach, Germany. He has made significant contributions to the field of immunology, particularly in the development of treatments for rotavirus infections. With a total of 2 patents, Olichon has focused on innovative solutions that address critical health challenges.

Latest Patents

Olichon's latest patents include groundbreaking work on monomeric and dimeric VHH domains derived from anti-VP6 camelid antibodies. These patents detail immunization methods, compositions, and treatment methods for rotavirus infections. The domains described in his patents are designed to bind to protein VP6 of Group A rotavirus, showcasing his commitment to advancing medical science. His work includes a comprehensive approach to rotavirus detection and prevention, further emphasizing the importance of his research in public health.

Career Highlights

Throughout his career, Aurelien Olichon has worked with esteemed organizations such as the National Institute of Agricultural Technology (INTA). His experience in these institutions has allowed him to collaborate with leading experts in the field, enhancing his research and innovation capabilities.

Collaborations

Olichon has collaborated with notable colleagues, including Thomas Surrey and Lorena Laura Garaicoeachea. These partnerships have contributed to the depth and breadth of his research, fostering an environment of innovation and discovery.

Conclusion

Aurelien Olichon stands out as a dedicated inventor whose work in rotavirus treatment has the potential to make a significant impact on global health. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…